Search

everythinglearnresearchcommunity

for

Search:↓

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

Tacrolimus is a better option than cyclosporine due to fewer side effects.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Trametinib can effectively treat severe kaposiform lymphangiomatosis when other treatments fail.

Baricitinib effectively promotes regrowth of eyebrows and eyelashes in alopecia areata patients.

Topical ruxolitinib quickly improves non-segmental vitiligo.

Topical tofacitinib may help regrow hair in children with alopecia totalis.

Vaccines and targeting TrxR variants can help prevent cancer and reduce metastasis.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Thalidomide with CHOP is more effective for peripheral T-cell lymphoma than CHOP alone.

A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.

LGD1069 effectively prevents breast tumors in mice without toxicity.

Topical tofacitinib may grow hair better than minoxidil by increasing VEGF and reducing inflammation.

Baricitinib is widely used for several conditions, especially COVID-19, but its safety and effectiveness are still being evaluated.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

Bolandiol, a synthetic steroid, builds muscle and bone without greatly affecting sex glands, and works differently from other hormones.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Increasing the dose of baricitinib to 4 mg helps more patients with severe alopecia areata regrow hair.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Bicalutamide does not significantly affect liver enzymes and is a safe anti-androgen option for transfeminine individuals.

AD198 is more effective than doxorubicin in stopping certain dog cancer cells.

Baricitinib improved nail condition and hair regrowth in a patient with alopecia and nail abnormalities.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Ablative fractional laser treatment nearly matches the gene reduction effects of topical vismodegib in skin cancer.